Cancer Immunotherapy at the Crossroads - How Tumors Evade Immunity and What Can Be Done (Paperback, Softcover reprint of the original 1st ed. 2004)

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.

General

Imprint:	HumanaPress
Country of origin:	United States
Series:	Current Clinical Oncology
Release date:	August 2012
First published:	2004
Editors:	James H. Finke • Ronald M. Bukowski
Dimensions:	229 x 152 x 21mm (L x W x T)
Format:	Paperback
Pages:	386
Edition:	Softcover reprint of the original 1st ed. 2004
ISBN-13:	978-1-4684-9844-8
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	1-4684-9844-4
Barcode:	9781468498448

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!